Shigella Conjugate Vaccine from Mexico
Polysaccharide-protein conjugate vaccine targeting Shigella flexneri for diarrheal disease prophylaxis. Classified in HTS 3002.49.0050 as other immunological product from microbial cultures, modified biotechnologically for therapeutic use.
Duty Rate — Mexico → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Include conjugate linkage details in specs; FDA biologics surveillance applies
• Certify sterility and adjuvant absence if applicable; use insulated shippers